{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:34:10Z","timestamp":1788910450618,"version":"build-2803163510"},"reference-count":84,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205618","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T15:55:11Z","timestamp":1709654111000},"source":"Crossref","is-referenced-by-count":2,"title":["miR-26a-5p inhibits the proliferation of psoriasis-like keratinocytes in vitro and in vivo by dual interference with the CDC6\/CCNE1 axis"],"prefix":"10.18632","author":[{"given":"Jianing","family":"Li","sequence":"first","affiliation":[{"name":"Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University, Changchun 130062, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxin","family":"Pang","sequence":"additional","affiliation":[{"name":"Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University, Changchun 130062, China"},{"name":"Chongqing Research Institute, Jilin University, Chongqing 401123, China"},{"name":"Chongqing Jitang Biotechnology Research Institute Co., Ltd., Chongqing 401123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Joint International Research Laboratory of Reproduction and Development, School of Basic Medicine, Chong-qing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University, Changchun 130062, China"},{"name":"Chongqing Research Institute, Jilin University, Chongqing 401123, China"},{"name":"Chongqing Jitang Biotechnology Research Institute Co., Ltd., Chongqing 401123, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology, First Bethune Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Lab for Zoonoses Research, Ministry of Education, College of Animal Sciences, Jilin University, Changchun 130062, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis.","volume":"9","author":"Yan","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis.","volume":"3","author":"Krueger","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000486304","article-title":"Pathogenesis of Psoriasis: Focus on Autoinflammation.","volume":"5","author":"Berti","year":"2018","journal-title":"Dermatopathology (Basel)"},{"key":"4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis.","volume":"38","author":"Sch\u00f6n","year":"2015","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","article-title":"The prevalence of psoriasis in the world.","volume":"1","author":"Farber","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis.","volume":"3","author":"John","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis--epidemiology and clinical spectrum.","volume":"2","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies.","volume":"14","author":"Krueger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"7","author":"Isaacs","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk Factors for the Development of Psoriasis.","volume":"2","author":"Ohtsuki","year":"2019","journal-title":"Int J Mol Sci"},{"key":"11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental risk factors and epigenetic alternations in psoriasis.","volume":"2","author":"Walecka","year":"2020","journal-title":"Ann Agric Environ Med"},{"key":"12","doi-asserted-by":"publisher","first-page":"14513","DOI":"10.1038\/s41598-018-32522-y","article-title":"Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway.","volume":"8","author":"Zheng","year":"2018","journal-title":"Sci Rep"},{"key":"13","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3892\/ijo_00000799","article-title":"Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.","volume":"3","author":"Mallya","year":"2010","journal-title":"Int J Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0625.1995.tb00215.x","article-title":"Cell cycle regulators in the keratinocyte (cyclin-cdk).","volume":"4","author":"Kitagawa","year":"1995","journal-title":"Exp Dermatol"},{"key":"15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.prp.2015.09.014","article-title":"High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.","volume":"21","author":"Su","year":"2016","journal-title":"Pathol Res Pract"},{"key":"16","doi-asserted-by":"publisher","first-page":"40362","DOI":"10.18632\/oncotarget.9616","article-title":"Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41419-019-1510-8","article-title":"Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.","volume":"1","author":"Xu","year":"2019","journal-title":"Cell Death Dis"},{"key":"18","doi-asserted-by":"publisher","first-page":"16810","DOI":"10.1038\/s41598-022-20769-5","article-title":"CDK4\/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1\/S transition.","volume":"1","author":"Yang","year":"2022","journal-title":"Sci Rep"},{"key":"19","doi-asserted-by":"publisher","first-page":"e12785","DOI":"10.7554\/eLife.12785","article-title":"Opposing roles for DNA replication initiator proteins ORC1 and CDC6 in control of Cyclin E gene transcription.","volume":"5","author":"Stillman","year":"2016","journal-title":"Elife"},{"key":"20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2133.2011.10497.x","article-title":"microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris.","volume":"16","author":"Ihn","year":"2011","journal-title":"Br J Dermatol"},{"key":"21","doi-asserted-by":"publisher","first-page":"e90284","DOI":"10.1371\/journal.pone.0090284","article-title":"IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model.","volume":"9","author":"Krueger","year":"2014","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/MIB.0000000000000121","article-title":"IL-17A alone weakly affects the transcriptome of intestinal epithelial cells but strongly modulates the TNF-\u03b1-induced expression of inflammatory mediators and inflammatory bowel disease susceptibility genes.","volume":"2","author":"Brand","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41419-021-04230-5","article-title":"MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.","volume":"1","author":"Shen","year":"2021","journal-title":"Cell Death Dis"},{"key":"24","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4161\/cc.7.20.6833","article-title":"Control of cell proliferation pathways by microRNAs.","volume":"7","author":"Malumbres","year":"2008","journal-title":"Cell Cycle"},{"key":"25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/JID.2015.409","article-title":"microRNAs in Psoriasis.","volume":"13","author":"O'Connell","year":"2016","journal-title":"J Invest Dermatol"},{"key":"26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1515\/med-2016-0063","article-title":"MicroRNAs as regulatory elements in psoriasis.","volume":"1","author":"Liu","year":"2016","journal-title":"Open Med (Wars)"},{"key":"27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbrc.2016.01.157","article-title":"MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.","volume":"47","author":"Li","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.prp.2016.11.020","article-title":"MicroRNA-194 regulates keratinocyte proliferation and differentiation by targeting Grainyhead-like 2 in psoriasis.","volume":"21","author":"Su","year":"2017","journal-title":"Pathol Res Pract"},{"key":"29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1691\/ph.2017.7018","article-title":"MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5) \/ FZD8 through \u03b2-catenin signaling in psoriasis.","volume":"7","author":"Yang","year":"2017","journal-title":"Pharmazie"},{"key":"30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopha.2017.05.005","article-title":"MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1.","volume":"9","author":"Yang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"31","doi-asserted-by":"publisher","first-page":"14186","DOI":"10.1038\/s41598-021-93616-8","article-title":"MicroRNA-378a-3p is overexpressed in psoriasis and modulates cell cycle arrest in keratinocytes via targeting BMP2 gene.","volume":"1","author":"Wongpiyabovorn","year":"2021","journal-title":"Sci Rep"},{"key":"32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jconrel.2017.11.013","article-title":"Towards topical microRNA-directed therapy for epidermal disorders.","volume":"26","author":"Ross","year":"2018","journal-title":"J Control Release"},{"key":"33","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1158\/1541-7786.MCR-13-0641","article-title":"MicroRNA-26a\/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer.","volume":"1","author":"He","year":"2014","journal-title":"Mol Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"1","author":"Anders","year":"2014","journal-title":"Genome Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.","volume":"4","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs.","volume":"4","author":"Bartel","year":"2015","journal-title":"Elife"},{"key":"37","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","article-title":"miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.","volume":"4","author":"Jian","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","article-title":"miRDB: an online resource for microRNA target prediction and functional annotations.","volume":"4","author":"Wang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets.","volume":"4","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","article-title":"RNAhybrid: microRNA target prediction easy, fast and flexible.","volume":"3","author":"Rehmsmeier","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"1","author":"Ideker","year":"2003","journal-title":"Genome Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41556-021-00696-9","article-title":"Global profiling of RNA-binding protein target sites by LACE-seq.","volume":"2","author":"Lei","year":"2021","journal-title":"Nat Cell Biol"},{"key":"43","doi-asserted-by":"publisher","first-page":"D148","DOI":"10.1093\/nar\/gkz896","article-title":"miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database.","volume":"4","author":"Cai","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis.","volume":"18","author":"Lubberts","year":"2009","journal-title":"J Immunol"},{"key":"45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"2","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"46","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.3390\/ijms222111574","article-title":"Current Concepts of Psoriasis Immunopathogenesis.","volume":"2","author":"Massari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"47","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.3390\/ijms21165781","article-title":"The Role of MicroRNAs in Epidermal Barrier.","volume":"2","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"key":"48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 Signaling Pathway and the Treatment of Psoriasis.","volume":"20","author":"Krueger","year":"2018","journal-title":"J Immunol"},{"key":"49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12026-020-09149-1","article-title":"The role of Th17 cells in psoriasis.","volume":"6","author":"Fang","year":"2020","journal-title":"Immunol Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/PTT.S98893","article-title":"Targeting IL-23 in psoriasis: current perspectives.","volume":"8","author":"Ioannides","year":"2018","journal-title":"Psoriasis (Auckl)"},{"key":"51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.","volume":"3","author":"Krueger","year":"2013","journal-title":"Trends Immunol"},{"key":"52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.1971.04000130035004","article-title":"Methotrexate for psoriasis. A new therapeutic schedule.","volume":"10","author":"Frost","year":"1971","journal-title":"Arch Dermatol"},{"key":"53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13277-012-0611-0","article-title":"Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors.","volume":"3","author":"Nagy","year":"2013","journal-title":"Tumour Biol"},{"key":"54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2133.1976.tb07028.x","article-title":"The cell cycle in psoriasis: a reappraisal.","volume":"9","author":"Gelfant","year":"1976","journal-title":"Br J Dermatol"},{"key":"55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1046\/j.1468-3083.2000.00058.x","article-title":"Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.","volume":"1","author":"Rytter","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"56","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer.","volume":"43","author":"Massagu\u00e9","year":"2004","journal-title":"Nature"},{"key":"57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.genet.39.110304.095808","article-title":"Cell-cycle control of gene expression in budding and fission yeast.","volume":"3","author":"B\u00e4hler","year":"2005","journal-title":"Annu Rev Genet"},{"key":"58","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1038\/onc.2016.32","article-title":"Targeting the RB-E2F pathway in breast cancer.","volume":"3","author":"Bernards","year":"2016","journal-title":"Oncogene"},{"key":"59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control.","volume":"8","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1747-1028-7-10","article-title":"The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle.","volume":"7","author":"Dick","year":"2012","journal-title":"Cell Div"},{"key":"61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0959-437x(98)80058-0","article-title":"Regulation of cell proliferation by the E2F transcription factors.","volume":"8","author":"Helin","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"62","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1101\/gad.892101","article-title":"Control of cell division by a retinoblastoma protein homolog in Chlamydomonas.","volume":"1","author":"Goodenough","year":"2001","journal-title":"Genes Dev"},{"key":"63","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.molcel.2021.03.003","article-title":"Multiple, short protein binding motifs in ORC1 and CDC6 control the initiation of DNA replication.","volume":"8","author":"Stillman","year":"2021","journal-title":"Mol Cell"},{"key":"64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/19491034.2018.1516484","article-title":"Nonreplicative functions of the origin recognition complex.","volume":"9","author":"Kopytova","year":"2018","journal-title":"Nucleus"},{"key":"65","first-page":"1173","article-title":"Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.","volume":"1","author":"Weinberg","year":"1996","journal-title":"Oncogene"},{"key":"66","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/exd.13750","article-title":"RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes.","volume":"2","author":"Son","year":"2018","journal-title":"Exp Dermatol"},{"key":"67","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1126\/science.8475385","article-title":"Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.","volume":"26","author":"Massagu\u00e9","year":"1993","journal-title":"Science"},{"key":"68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers.","volume":"2","author":"Mi","year":"2017","journal-title":"Exp Dermatol"},{"key":"69","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3899\/jrheum.190602","article-title":"Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis.","volume":"4","author":"Veale","year":"2020","journal-title":"J Rheumatol"},{"key":"70","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3899\/jrheum.150232","article-title":"Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.","volume":"4","author":"Stein","year":"2015","journal-title":"J Rheumatol"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10475-w","article-title":"The Role of lncRNA-miR-26a-mRNA Network in Cancer Progression and Treatment.","author":"Wang","year":"2023","journal-title":"Biochem Genet"},{"key":"72","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jconrel.2020.04.038","article-title":"Topical delivery of siRNA into skin using ionic liquids.","volume":"32","author":"Mitragotri","year":"2020","journal-title":"J Control Release"},{"key":"73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","article-title":"Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.","volume":"4","author":"Greis","year":"2017","journal-title":"Exp Hematol"},{"key":"74","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1093\/nar\/gkr1278","article-title":"MicroRNA-26a\/b and their host genes cooperate to inhibit the G1\/S transition by activating the pRb protein.","volume":"4","author":"Zhuang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"75","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1089\/scd.2016.0203","article-title":"miR-26a Mediates Adipogenesis of Amniotic Fluid Mesenchymal Stem\/Stromal Cells via PTEN, Cyclin E1, and CDK6.","volume":"2","author":"Roubelakis","year":"2017","journal-title":"Stem Cells Dev"},{"key":"76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08916934.2021.1897976","article-title":"LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation.","volume":"5","author":"Yu","year":"2021","journal-title":"Autoimmunity"},{"key":"77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression.","volume":"3","author":"Gershwin","year":"2009","journal-title":"J Autoimmun"},{"key":"78","doi-asserted-by":"publisher","first-page":"e31422","DOI":"10.1371\/journal.pone.0031422","article-title":"Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.","volume":"7","author":"Shimizu","year":"2012","journal-title":"PLoS One"},{"key":"79","doi-asserted-by":"publisher","first-page":"41309","DOI":"10.1038\/srep41309","article-title":"The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene.","volume":"7","author":"Eroles","year":"2017","journal-title":"Sci Rep"},{"key":"80","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.2147\/CMAR.S261131","article-title":"MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1.","volume":"1","author":"Zhang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1093\/nar\/gks855","article-title":"Estrogen-induced upregulation and 3'-UTR shortening of CDC6.","volume":"4","author":"Erson-Bensan","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.51","article-title":"Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression.","author":"Mokhtari-Azad","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"83","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature25507","article-title":"Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress.","volume":"55","author":"Halazonetis","year":"2018","journal-title":"Nature"},{"key":"84","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3892\/or.2014.2971","article-title":"MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.","volume":"3","author":"Fang","year":"2014","journal-title":"Oncol Rep"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T15:55:19Z","timestamp":1709654119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":84,"alternative-id":["205618"],"URL":"https:\/\/doi.org\/10.18632\/aging.205618","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}